SCHEMBL29566612

SCHEMBL29566612

Cc1cccc(C)c1-c1cc(Oc2ccccc2)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ HTR1A P08908 5/20 0.41
▸ HTR7 P34969 5/20 0.41
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ GPR39 O43194 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ EGFR P00533 1/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ BRD4 O60885 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310345 1.00 TSHR (0.43) TSHRSMN1; SMN2HTR1AHTR7KDM4E
SCHEMBL26810050 0.94 HTR1A (0.42) TSHRSMN1; SMN2HTR1AHTR7KDM4E
SCHEMBL26810238 0.92 SMN1; SMN2 (0.38) TSHRSMN1; SMN2HTR1AHTR7KDM4E
SCHEMBL26810218 0.92 KMT2A (0.40) TSHRSMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL29566748 0.92 GAA (0.40) TSHRSMN1; SMN2HTR1AHTR7KDM4E
SCHEMBL24310086 0.92 GAA (0.40) TSHRSMN1; SMN2HTR1AHTR7KDM4E
SCHEMBL29566838 0.91 GFER (0.39) TSHRSMN1; SMN2HTR1AHTR7LMNA
SCHEMBL24310039 0.91 GFER (0.39) TSHRSMN1; SMN2HTR1AHTR7LMNA
SCHEMBL26857058 0.91 TSHR (0.36) TSHRSMN1; SMN2HTR1AHTR7GPR39
SCHEMBL24309574 0.90 BRD4 (0.41) TSHRSMN1; SMN2HTR1AHTR7HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback